Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New study of more than 1 million people shows statins are safe for people with common neuropsychiatric outcomes, such as new episodes of suicidal behaviours, depression, anxiety or seizures.

Is it safe to take statin? Yes / No

The Oxford University led population-based longitudinal study, included 1,149,384 individuals, of whom 1,015, 949 (84 per cent) were aged 50 years and older. The study period looked at data from January 2006 to December 2013 and used Swedish nationwide registers, which identified people who were dispensed statins, i.e. had filled in prescriptions, and were aged 15 years or older.

The investigation also found a reduced rate of depression in those prescribed statins, which requires further research to understand.

Professor Seena Fazel, Department of Psychiatry, University of Oxford, said, 

 

Statins are very widely used medications in the general population, and it is important to carefully investigate possible long-term effects. We have done this with regard to common neuropsychiatric outcomes, and found no increased associations. We also found a reduction in depression in those taking statins, although can’t be certain if this is caused by the statins, or indirectly through improved adherence with all medications and more regular contacts with healthcare. This apparent protective effect needs further examination.

The study looked at rates of these neuropsychiatric outcomes (new episodes of suicidal behaviours, depression, anxiety or seizures) when people were prescribed the statins compared to the same individuals when they were not. It found that the rates of suicidal behaviour or suicide death, anxiety disorder and seizures were unchanged. In the study, 23,745 people (2.1 per cent) had a new episode of depression during the follow-up period of up to 8 years, with a 9 per cent reduction in new outpatient or inpatient contacts for depression when they were taking statins, compared to when they were not. The authors found evidence of reduced associations with depression when the sample of people were dispensed other medications, such as antihistamines and diuretics.

Funding for this study has been received from the Wellcome Trust, Swedish Research Council, National Institute for Health Research (NIHR) Research Professorship, NIHR Oxford Health Biomedical Research Centre, the American Foundation for Suicide Prevention, and the Karolinska Institutet.

To read the full paper, published in The Lancet PsychiatryAssociations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New Way of Understanding Dissociation Could Improve Patient Care

Mental Health Psychosis

New research has developed a novel measure of dissociative experiences that share a subjective 'felt sense of anomaly'. This new approach could revolutionise how clinicians understand dissociative experiences across a range of mental health disorders, and how they work with patients with dissociation in the future.

Covid-19 vaccination programme: where do people with mental health difficulties lie within the order of priority?

COVID-19 Mental Health

A new blog authored by mental health clinicians and researchers in the Department of Psychiatry and Oxford Health NHS Foundation Trust, and published in thebmjopinion, discusses the priority groups for COVID-19 vaccinations.

New Analysis Challenges Guidelines on Treating Anorexia Nervosa

Mental Health Psychological therapy

A new analysis, published in The Lancet Psychiatry, has shown a lack of strong evidence to support current guidance on psychological therapies for treating anorexia nervosa over expert treatment as usual.

Children’s Mental Health Worse in the New Lockdown

Anxiety COVID-19 Child and adolescent Early intervention Mental Health Psychological therapy

The proportion of secondary school aged girls with emotional problems in January 2021 was at the highest level reported since March 2020, highlights latest report from the Co-SPACE study. It also shows parent and carer reported behavioural, emotional, and restless/attentional difficulties in their offspring have increased again since the latest national lockdown was introduced.

New WA Handley Chair of Psychiatry Appointed

Awards Mental Health

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021. He will be a fellow of Merton College. A donation from the WA Handley Trust endowed the first Chair of Psychiatry in the University of Oxford’s Department of Psychiatry, which was founded in 1969.

Improving Experiences of People with Serious Mental Health Problems

Mental Health

A project led by Professor Kam Bhui and Dr Roisin Mooney, University of Oxford, will focus on reducing the number of people admitted or readmitted to compulsory care under the Mental Health Act. This is one of four new research projects funded by the National Institute for Health Research (NIHR) with the aim to improve patient experiences and outcomes under the Mental Health Act.